Autoantibodies to IgG/HLA class II complexes are associated with rheumatoid arthritis susceptibility

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 10, 2014, Pages 3787-3792

  Jin, Hui ^a,b   Arase, Noriko ^a,c   Hirayasu, Kouyuki ^a   Kohyama, Masako ^a,b   Suenaga, Tadahiro ^a,b   Saito, Fumiji ^b   Tanimura, Kenji ^b   Matsuoka, Sumiko ^b   Ebina, Kosuke ^c   Shi, Kenrin ^c   Toyama Sorimachi, Noriko ^d   Yasuda, Shinsuke ^e   Horita, Tetsuya ^e   Hiwa, Ryosuke ^a,b,f   Takasugi, Kiyoshi ^g   Ohmura, Koichiro ^f   Yoshikawa, Hideki ^c   Saito, Takashi ^a,h   Atsumi, Tatsuya ^e   Sasazuki, Takehiko ⁱ   Katayama, Ichiro ^c   Lanier, Lewis L ^j   Arase, Hisashi ^a,b,k   more..

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^e HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f KYOTO UNIVERSITY   (Japan)

^g Dohgo Spa Hospital   (Japan)

^h RIKEN Center for Integrative Medical Sciences   (Japan)

ⁱ KYUSHU UNIVERSITY   (Japan)

^j UNIVERSITY OF CALIFORNIA   (United States)

^k JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

more..

Author keywords

Autoimmune disease; Major histocompatibility complex

Indexed keywords

AUTOANTIBODY; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; RHEUMATOID FACTOR;

ALLELE; ANTIGEN BINDING; ANTIGEN SPECIFICITY; ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CELL SURFACE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; HEAVY CHAIN; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FOLDING; RHEUMATOID ARTHRITIS;

AUTOIMMUNE DISEASE; MAJOR HISTOCOMPATIBILITY COMPLEX;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; DISEASE SUSCEPTIBILITY; DNA PRIMERS; DNA, COMPLEMENTARY; FLOW CYTOMETRY; HEK293 CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN G; IMMUNOPRECIPITATION; ODDS RATIO; PLASMIDS; PROTEIN FOLDING;

EID: 84896258752     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1401105111     Document Type: Article

References (35)

1. Dörner T, Egerer K, Feist E, Burmester GR (2004) Rheumatoid factor revisited. Curr Opin Rheumatol 16(3):246-253.
2. Jones EY, Fugger L, Strominger JL, Siebold C (2006) MHC class II proteins and disease: A structural perspective. Nat Rev Immunol 6(4):271-282.
3. Neefjes J, Jongsma ML, Paul P, Bakke O (2011) Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol 11(12):823-836.
4. Chicz RM, et al. (1993) Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med 178(1):27-47.
5. Nicholson MJ, Hahn M, Wucherpfennig KW (2005) Unusual features of self-peptide/MHC binding by autoimmune T cell receptors. Immunity 23(4):351-360.
6. Raychaudhuri S, et al. (2012) Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet 44(3): 291-296.
7. Newton JL, Harney SM, Wordsworth BP, Brown MA (2004) A review of the MHC genetics of rheumatoid arthritis. Genes Immun 5(3):151-157.
8. Jiang Y, et al. (2013) Transport of misfolded endoplasmic reticulum proteins to the cell surface by MHC class II molecules. Int Immunol 25(4):235-246.
9. Hayden JB, McCormack AL, Yates JR, 3rd, Davey MP (1996) Analysis of naturally processed peptides eluted from HLA DRB1*0402 and *0404. J Neurosci Res 45(6):795-802.
10. Harindranath N, et al. (1991) Complete sequence of the genes encoding the VH and VL regions of low-and high-affinity monoclonal IgM and IgA1 rheumatoid factors pro duced by CD5+ B cells from a rheumatoid arthritis patient. Int Immunol 3(9):865-875.
11. Burastero SE, Casali P, Wilder RL, Notkins AL (1988) Monoreactive high affinity and polyreactive low affinity rheumatoid factors are produced by CD5+ B cells from pa tients with rheumatoid arthritis. J Exp Med 168(6):1979-1992.
12. Schulze MS, Wucherpfennig KW (2012) The mechanism of HLA-DM induced peptide exchange in the MHC class II antigen presentation pathway. Curr Opin Immunol 24(1): 105-111.
13. Söderberg O, et al. (2006) Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods 3(12):995-1000.
14. Cresswell P (1994) Assembly, transport, and function of MHC class II molecules. Annu Rev Immunol 12:259-293.
15. Davenport MP, etal. (1995) Naturally processed peptides from two disease-resistance-associated HLA-DR13 alleles show related sequence motifs and the effects of the dimorphism at position 86 of the HLA-DR β chain. Proc Natl Acad Sci USA 92(14): 6567-6571.
16. Patil NS, et al. (2001) Rheumatoid arthritis (RA)-associated HLA-DR alleles form less stable complexes with class II-associated invariant chain peptide than non-RA-asso-ciated HLA-DR alleles. J Immunol 167(12):7157-7168.
17. Muntasell A, et al. (2002) HLA-DR4 molecules in neuroendocrine epithelial cells as sociate to a heterogeneous repertoire of cytoplasmic and surface self peptides. J Im munol 169(9):5052-5060.
18. Seward RJ, Drouin EE, Steere AC, Costello CE (2011) Peptides presented by HLA-DR molecules in synovia of patients with rheumatoid arthritis or antibiotic-refractory Lyme arthritis. Mol Cell Proteomics 10(3):002477.
19. Castellino F, Zappacosta F, Coligan JE, Germain RN (1998) Large protein fragments as substrates for endocytic antigen capture by MHC class II molecules. J Immunol 161 (8): 4048-4057.
20. Sercarz EE, Maverakis E (2003) Mhc-guided processing: Binding of large antigen fragments. Nat Rev Immunol 3(8):621-629.
21. Nielsen SF, Bojesen SE, Schnohr P, Nordestgaard BG (2012) Elevated rheumatoid factor and long term risk of rheumatoid arthritis: A prospective cohort study. BMJ 345:e5244.
22. Bonagura VR, et al. (1993) Mapping studies reveal unique epitopes on IgG recognized by rheumatoid arthritis-derived monoclonal rheumatoid factors. J Immunol 151(7): 3840-3852.
23. Sasso EH, Barber CV, Nardella FA, Yount WJ, Mannik M (1988) Antigenic specificities of human monoclonal and polyclonal IgM rheumatoid factors. The C γ 2-C γ 3 in terface region contains the major determinants. J Immunol 140(9):3098-3107.
24. Milosevic-Jovcic N, Ciric D, Hajdukovic-Dragojlovic L, Mircetic V (2004) Differences in the relationship of specificity to titre and functional affinity between circulating Ga-and pan-reactive IgM rheumatoid factors in rheumatoid arthritis. Rheumatology (Oxford) 43(9):1190-1193.
25. Matsumoto I, et al. (2002) How antibodies to a ubiquitous cytoplasmic enzyme may provoke joint-specific autoimmune disease. Nat Immunol 3(4):360-365.
26. Griffiths MM, Remmers EF (2001) Genetic analysis of collagen-induced arthritis in rats: A polygenic model for rheumatoid arthritis predicts a common framework of cross-species inflammatory/autoimmune disease loci. Immunol Rev 184:172-183.
27. Reimold AM, et al. (2001) Plasma cell differentiation requires the transcription factor XBP-1. Nature 412(6844):300-307.
28. Théry C, Ostrowski M, Segura E (2009) Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 9(8):581-593.
29. Suzuki A, et al. (2003) Functional haplotypes of PADI4, encoding citrullinating en zyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet 34 (4): 395-402.
30. Schellekens GA, et al. (2000) The diagnostic properties of rheumatoid arthritis anti bodies recognizing a cyclic citrullinated peptide. Arthritis Rheum 43(1):155-163.
31. Tarcsa E, et al. (1996) Protein unfolding by peptidylarginine deiminase. Substrate specificity and structural relationships of the natural substrates trichohyalin and fi-laggrin. J Biol Chem 271(48):30709-30716.
32. Arnett FC, et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315-324.
33. Tan EM, et al. (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25(11):1271-1277.
34. Miyakis S, et al. (2006) International consensus statement on an update of the clas sification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4(2):295-306.
35. Scott CA, Peterson PA, Teyton L, Wilson IA (1998) Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues. Immunity 8(3):319-329.